Tripeptide-29
CosmeticCosmetic skincare peptide
Last updated 29 October 2026
Tripeptide-29 is a small peptide used in skincare, marketed to support collagen and skin firmness. Used with no medicinal claims, it is regulated as a cosmetic ingredient. The evidence is modest.
Key points
- Tripeptide-29 is a three amino acid peptide added to skincare products.
- It is marketed to support collagen and the firmness of the skin.
- On the skin, with no medicinal claims, it is regulated as a cosmetic ingredient in the UK.
- The evidence is modest, and cosmetic claims are best kept in proportion.
Quick facts
- What it is
- Cosmetic skincare peptide (Tripeptide-29)
- Marketed for
- Collagen support and firmness
- UK status
- Legal as a cosmetic ingredient (no medicinal claims)
- Evidence
- Modest
How it works
Short peptides like this are used in cosmetics with the aim of signalling to skin cells to support collagen, the protein that gives skin its structure. Most of the supporting evidence is from laboratory and manufacturer studies.
What the evidence shows
There are studies, often from manufacturers, suggesting modest improvements in the look and firmness of skin. Independent, high quality trials are limited, so claims should be kept modest.
What it does not settle
- Independent high quality evidence is limited.
- Effects are usually modest and build slowly.
- Results depend on the product and how it is used.
Side effects
Common
- Usually well tolerated, though some people get mild irritation or redness. A patch test is sensible.
Report any suspected side effect through the MHRA Yellow Card scheme.
UK legal status and access
As a topical cosmetic ingredient with no medicinal claims, Tripeptide-29 is legal and widely sold in skincare. Any version sold with medicinal claims would fall under medicines rules.
Common questions
Is Tripeptide-29 legal in the UK?
Yes, as a cosmetic ingredient used with no medicinal claims.
Does it work?
It may give modest improvements in the look of skin, but independent evidence is limited and effects build slowly.
Factual reference only, not medical advice. We give no dosing for unlicensed compounds.